期刊文献+

心肌肌钙蛋白I异常病人血清结缔组织生长因子表达的研究 被引量:1

Significance of connective tissue growth factor in cardiac troponin I dysfunction patients
下载PDF
导出
摘要 目的:检测心肌肌钙蛋白I(cTn I)异常病人血清中结缔组织生长因子(CTGF)水平的变化,探讨CTGF在心肌损伤病人血清中表达的意义。方法:化学发光法检测血清中cTn I水平,并根据cTn I水平分组;利用生物素亲和素EIA分析法检测各组病人血清中CTGF水平。结果:80例病人血清标本按cTn I水平分为Ⅰ、Ⅱ、Ⅲ3组,CTGF平均水平依次为(13.04±6.85)、(21.67±8.35)及(35.06±24.12)ng.m l-1。其中,Ⅱ、Ⅲ组血清CTGF水平明显高于正常对照组(均P<0.05),Ⅰ组与正常对照组比较差异不显著(P>0.05),Ⅱ、Ⅲ组与Ⅰ组比较差异显著(均P<0.05),Ⅱ组与Ⅲ组比较差异显著(P<0.05)。结论:CTGF在心肌损伤以及心肌梗死后表达上调,可能与心肌纤维化关系密切。 Objective To detect the levels of connective tissue growth factor(CTGF) in the sera of cardiac troponin I dysfunction patients and to investigate the meaning of CTGF in patients with myocardial damage. Methods The levelsof cardiac troponin I ( cTn I) were detected by chemoluminescence assay in the sera. According to cTn I concentration, CTGF levels of different groups were also determined using an avidin-biotin-EIA. Results The patients were divided into three groups according to cTn I levels. The average concentrations of CTGF were ( 13.04 ± 6.85 ) ng ·ml^-1 in group Ⅰ ,(21.67 ±8.35)ng ·ml^-1 in group Ⅱ and (35.06 ±24. 12)ng ·ml^-1 in group Ⅲ respectively. CTGF levels of group H and group Ⅲ significantly were increased as compared with control group and group Ⅰ ( all P 〈 0. 05 ). There was a statistical significance between group H and group Ⅲ ( P 〈 0. 05 ). However, group Ⅰ had no significance as compared with control group ( P 〉 0. 05 ). Conclusion CTGF is correlated with myocardial fibrosis after myocardial damage ,or post-myocardiac infarction.
出处 《东南大学学报(医学版)》 CAS 2007年第3期166-169,共4页 Journal of Southeast University(Medical Science Edition)
基金 国家自然科学基金资助项目(30070300)
关键词 心肌肌钙蛋白I 结缔组织生长因子 心肌损伤 心肌梗死 心肌纤维化 cardiac troponin I connective tissue growth factor myocardial damage myocardial infarction fibrosis
  • 相关文献

参考文献1

二级参考文献12

  • 1Beltrami AP, Urbanek K, Kajstura J, et al. Evidence that human cardiac myocytes divide after myocardial infarction[ J]. N E ngl J Med, 2001,344(23): 1750-1757.
  • 2Beltrami AP, Barlucchi L, Torella D, et al. Adult cardiac stem cells are multipotent and support myocardial regeneration [ J ]. Cell, 2003, 114(6) :763-776.
  • 3Tomita S, Li R-K, Weisel RD, et al. Autologous transplantation of bone marrow cells improves damaged heart function [ J ]. Circulation, 1999,100(Suppl Ⅱ ): 247-256.
  • 4Orlic D, Kajstura J, Chimenti S, et al. Bone marrow cells regenerate infarcted myocardium [ J ]. Nature, 2001,410 ( 6829 ): 701-705.
  • 5Jain M, DerSimonian H, Brenner DA, et al. Cell therapy attenuates deleterious ventricular remodeling and improves cardiac performance after myocardial infarction[J]. Circulation ,2001,103(14): 1920-1927.
  • 6Tomita S, Mickle DA, Weisel RD, et al. Improved heart function with myogenesis and angiogenesis after autologous porcine bone marrow stromal cells transplantation [ J]. J Thorac Cardiovasc Surg, 2002, 123(6): 1132-1140.
  • 7Pfeffer MA, Pfeffer JM, Fishbein MC, et al. Myocardial infarct size and ventricular function in rats[J]. Circ Res, 1979,44(4) :503-512.
  • 8Mulder P, Boujedaini H, Richard V, et al. Long-term survival and hemodynamics after endothelin-A receptor antagonism and angiotensinconverting enzyme inhibition in rats with chronic heart failure [ J ].Circulation, 2002,106:1159-1164.
  • 9Makino S,Fukuda K,Miyoshi S,et al. Cardiomyocytes can be generated from marrow stromal cells in vitro[J] .J Clin Invest,1999,103(5):697-705.
  • 10Fukuda K. Development of regenerative cardiomyocytes from mesenchymal stem cells for cardiovascular tissue engineering [ J ]. Artif Organs,2001,25(3): 187-193.

共引文献14

同被引文献25

  • 1何文静,张英杰.他汀类药物对心肌梗死后心室重构的作用[J].中国心血管病研究,2007,5(10):791-793. 被引量:2
  • 2NISHIOKA T,SUZUKI M,ONISHI K,et al.Eplerenone attenuatesm yocardial fibrosis in the angiotensin Ⅱ-induced hypertensive mouse:involvement of tenascin-C induced by aldosterone-mediated inflammation[J].J Cardiovasc Pharmacol,2007,49(5):261-268.
  • 3ANDRAE J,GALLINI R,BETSHOLTZ C.Role of platelet-derived growth factors in physiology and medicine[J].Genes Dev,2008,22(10):1276-1312.
  • 4TAKANO H,ZOU,Y,HASEGAWA H,et al.Oxidative stress-induced signal transduction pathways in cardiac myocytes:involvement of ROS in heart diseases[J].Antioxid Redox Signal,2003,5(6):789-794.
  • 5YASUNARI K,MAEDA K,MINAMI M,et al.HMG-CoA reductase inhibitors pre-vent migration of human coronary smooth muscle cells through suppression of increase in oxidative stress[J].Arterioscler Thromb Vasc Biol,2001,21:937-942.
  • 6CASTRO C,DIEZ-JUAN A,CORTES,M J,et al.Distinct regulation of mitogen-activated protein kinases and p27Kip1 in smooth muscle cells from different vascular beds.A potential role in establishing regional phenotypic variance[J].Biol Chem,2003,278:4482-4490.
  • 7TEA B S,DAM T V,MOREAU P,et al.Apoptosis during regression of cardiac hypertrophy in spontaneously hypertensive rats.Temporal regulation and spatial heterogeneity[J].Hyper-tension,1999,34(2):229-235.
  • 8BUEMI M,CORICA F,MARINO D,et al.Cardiovascular remodeling,apoptosis,and drugs[J].Am J Hypertens,2000,13:450-454.
  • 9YAN C,KOJI O,MIZUKI M,et al.Differential impact of atorvastatin vs pravastatin on progressive insulin resistance and left ventricular diastolic dysfunction in a rat model of type Ⅱ diabetes[J].Circ J,2007,71:144-152.
  • 10DAVIGNON J.Beneficial cardiovascular pleiotropic effects of statins[J].Circulation,2004,109:39-43.

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部